Abagovomab
Abagovomab Uses, Dosage, Side Effects, Food Interaction and all others data.
Abagovomab is under investigation in clinical trial NCT00418574 (Efficacy Multicentre Trial of Immunotherapy Vaccination With Abagovomab to Treat Ovarian Cancer Patients).
| Trade Name | Abagovomab |
| Generic | Abagovomab |
| Abagovomab Other Names | Abagovomab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Abagovomab
